Fact.MR, A Market Research And Competitive Intelligence Provider – The global Psychotic Disorder Treatment market is bound to be valued US$ 13.6 Bn in 2022 and have a CAGR of 6.1% between 2022 and 2032.
Increasing Prevalence Of Severe Psychotic Disorders And Rising Awareness Of Mental Health Issues Are Prime Factors Driving Market Growth In Europe Region.
Fact.MR, A Market Research And Competitive Intelligence Provider – The global Psychotic Disorder Treatment market is bound to be valued US$ 13.6 Bn in 2022 and have a CAGR of 6.1% between 2022 and 2032.
The Europe psychotic disorder treatment market accounts for a total valuation of US$ 3.45 billion in 2022 and holds a notable market share of 25.4% in the global industry landscape.
Stress levels among the general population have increased notably over the past few years and this has led to an increase in the incidence of psychotic disorders such as bipolar disorder, schizophrenia, etc.
Changes in lifestyle, the prevalence of stress-inducing global and economic conditions, high-stress environments, early onset of mental disorders in teenagers, and increasing prevalence of depression are other factors that could drive demand for psychotic disorder treatment equipment and drugs across the forecast period.
For more insights into the Market, Get A Sample of this Report!
https://www.factmr.com/connectus/sample?flag=S&rep_id=568
Key Takeaways from Market Study
- North America holds 21.3% of the overall psychotic disorder treatment market.
- Europe accounts for a quarter of the psychotic disorder treatment market.
- The psychotic disorder treatment market is expected to reach US$ 24.58 Bn by the year 2032.
- Second generation psychotic disorder treatment to dominate the market due to majority of treatment options belonging to this category.
“Growing prevalence of lifestyle-related mental conditions together with the increasing number of bipolar disorders is compelling the expansion of efficient-psychotic disorder treatment. Increasing number of patients suffering from schizophrenia, depressive disorders, bipolar disorders and other mental disorders are fast-tracking the growth for psychotic disorder treatment.” states Fact.MR.
Market Developments
The key participants in psychotic disorder treatment market include H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd., Janssen Pharmaceuticals, Inc., Eli Lilly and Company, Allergan (AbbVie, Inc.), Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Sumitomo Dainippon Pharma Co., Ltd., Alkermes plc, and Bristol-Myers Squibb Company.
- Alkermes plc, in February 2022, did receive positive results through ENLIGHTEN-Early. It comes across as a phase-III study assessing effect of olanzapine and samidorphan (LYBALVI) in comparison with olanzapine on the body weight, especially in patients aged between 16 and 39 with schizophrenia, bipolar I disorder or schizophreniform disorder.
- BioXcel Therapeutics, in April 2022, announced that its IGALMI (dexmedetomine) Sublingual Film was approved by the US FDA for treating bipolar disorder.
- AbbVie, in February 2022, announced submission of a Supplemental New Drug Application to the US FDA. It’s based on the results of new trial for cariprazine (VRAYLAR) to adjunctively treat MDD (major depressive disorder).
- Otsuka America Pharmaceutical, Inc., along with H. Lundbeck A/S, did receive approval from the US FDAfor supplemental novel drug application, better known as sNDA of REXULTI (brexpiprazole) to treat schizophrenia in patients aged between 13 and 17.
- Dr. Reddy’s Laboratories Ltd., in February 2021, did launch Fluphenazine Hydrochloride tablets known as “USP”. They are actually a generic form of Proxilin tablets (1 mg, 2.5 mg, 5 mg, and 10 mg) by the US FDA.
For Comprehensive Insights Ask An Analyst Here
https://www.factmr.com/connectus/sample?flag=AE&rep_id=568
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the psychotic disorder market, and the current trends and future estimations to elucidate the imminent investment pockets.
- It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing psychotic disorder market opportunities.
- Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
- Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the psychotic disorder market.
Segmentation of Psychotic Disorder Treatment Industry Research
- Psychotic Disorder Treatment Market by Drug Type :
- Atypical Antipsychotics
- Phenothiazine Antipsychotics
- Thioxanthenes
- Miscellaneous Antipsychotics Agents
- Psychotic Disorder Treatment Market by Indication :
- Schizophrenia
- Bipolar Disorder
- Delusional Disorder
- Drug Induced Psychosis
- Organic Psychosis
- Psychotic Disorder Treatment Market by Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Drug Store
- e-Commerce
- Psychotic Disorder Treatment Market by Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Get Customization on this Report for Specific Research Solutions
https://www.factmr.com/connectus/sample?flag=RC&rep_id=568
More Valuable Insights Available
Fact.MR, in its new offering, presents an unbiased analysis of the global Psychotic Disorder Treatment market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.
The study reveals essential insights by drug type (atypical antipsychotics, phenothiazine antipsychotics, thioxanthenes, and miscellaneous antipsychotics agents), by indication (schizophrenia, bipolar disorder, delusional disorder, drug induced psychosis, and organic psychosis), by distribution channel (hospital pharmacies, retail pharmacies, drug store, and e-Commerce), and by region (North America, LATAM, Europe, East Asia, South Asia & Oceania, and MEA).
Fact.MR’s Domain Knowledge on Healthcare
Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support - encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.
Explore Fact.MR’s Coverage on the Healthcare Domain
Anti-snoring Devices and Snoring Surgery Market - Anti-snoring Devices and Snoring Surgery Market By Device (Mandibular Advancement, Tongue Stabilizing, Continuous Positive Airway Pressure (CPAP)), By Surgical Procedure (Uvulopalatopharyngoplasty, Tonsillectomy and Adenoidectomy) - Regional Forecast 2021-2031
Antacids Market - Antacids Market Analysis Report By Drug Class (Proton Pump Inhibitors, H2 Antagonists), By Distribution Channel (Hospital, Retain Pharmacies), By Formulation, By Region - Global Market Insights 2020-2025
Antimicrobial Susceptibility Test Market - Antimicrobial Susceptibility Test Market Analysis Repot By Product (Kits, Reagents, & Consumables, Automated Test Systems, Culture Media), By Application (Clinical Diagnosis, Drug Discovery and Development), By End User, By Region - Global Insights 2020-2025
Anti-aging and Anti-wrinkle Products Market - Anti-aging and Anti-wrinkle Products Market Analysis Repot By Product (Serum, Creams, Gels), By Treatment (Body, Facial Care Treatment), By Ingredient (Retinoid, Hyaluronic Acids, Alpha-Hydroxy Acids), By Region - Global Insights 2020-2027
Anticoagulant Reversal Drugs Market - Anticoagulant Reversal Drugs Market Analysis Repot By Product (Prothrombin Complex Concentrates, Vitamin K, Protamine, Tranexamic Acid, Idarucizumab, Andexxa), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Region - Global Insights 2020-2026
Anticancer Drugs Market - Anticancer Drugs Market Analysis Repot By Drug Type (Targeted Drugs, Cytotoxic Drugs, Hormonal Drugs), By Cancer Type (Lung Cancer, Breast Cancer, Leukemia, Colorectal Cancer), By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy) - Global Market Forecast 2020-2025
Apheresis Market - Apheresis Market Analysis Repot By Technology (Centrifugation, Membrane Filtration), By Product (Devices, Disposables), By Application (Renal Diseases, Neurology, Haematology, Cancer, Autoimmune Diseases,Cardiovascular Diseases), By Region - Global Market Forecast 2020-2025
Aptamers Market - Aptamers Market Analysis Repot By Application (Research, Diagnostics, Therapeutics), By Selection Technique (SELEX Technique), By Material (Nucleic Acid Aptamers, Peptide Aptamers), By Region - Global Market Forecast to 2010-2025
Behavioural Health Treatment Market - Behavioural Health Treatment Market Analysis Report By Disorder (Depression, Anxiety, Schizophrenia, Bipolar Disorder, Alcohol Use Disorders, Substance Use Disorders, Eating Disorders, Post-traumatic Stress Disorders), By Service, By Region -Global Forecast 2020-2027
Assisted Reproductive Technology Market - Assisted Reproductive Technology Market Analysis Report By Procedure (Frozen Donor, Frozen Non-donor, Fresh Donor, Fresh Non-donor, Embryo Banking), By Technology (In-vitro Fertilization, Surrogacy, Artificial Insemination), By End User(Fertility Clinics, Hospitals, Other )- Global Market Insights to 2019-2025
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. 80% of Fortune 1000’s trusts us in critical decision making. We provide both qualitative and quantitative research, spanning market forecast, market segmentation, competitor analysis, and consumer sentiment analysis.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com